Literature DB >> 15364464

Waning immunity and subclinical measles infections in England.

K Glass1, B T Grenfell.   

Abstract

Following the introduction of vaccination against measles, levels of clinical infection have dropped markedly. As we move further into the vaccine era, increasingly many individuals owe their measles immunity to vaccination and have had few (if any) exposures to wild virus. A number of recent reports suggest that vaccinated individuals with low levels of immunity may be at risk of subclinical measles infection. We explore the interplay between levels of infection and immunity over time using a mathematical model that simulates infection, waning and boosting of immunity. We focus particularly on the situation in England, where vaccination has been in place since 1966. Simulations of our model demonstrate a rise in the levels of subclinical measles infection over time, and a corresponding rise in clinical measles infections if vaccination levels are too low. We compare the impact of intervention strategies, and find that the rise in cases is most effectively reduced by 'catch-up' vaccination of children. In recent years, vaccination levels in England have dropped from above 90% in the 1990s to 84% in 2001/2002. We discuss the impact of declining vaccination levels on clinical and subclinical infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364464     DOI: 10.1016/j.vaccine.2004.02.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

Authors:  Girish S Kirimanjeswara; Luis M Agosto; Mary J Kennett; Ottar N Bjornstad; Eric T Harvill
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

2.  The role of maternal antibodies in the emergence of severe disease as a result of fragmentation.

Authors:  David Fouchet; Stéphane Marchandeau; Nargès Bahi-Jaber; Dominique Pontier
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

3.  Implications of vaccination and waning immunity.

Authors:  J M Heffernan; M J Keeling
Journal:  Proc Biol Sci       Date:  2009-03-04       Impact factor: 5.349

4.  Exploring gaps in surveillance of a small measles outbreak in Toronto, Canada.

Authors:  E Gournis; A Shane; E Shane; A Arthur; L Berger
Journal:  Can Commun Dis Rep       Date:  2016-07-07

Review 5.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

6.  Real-time investigation of measles epidemics with estimate of vaccine efficacy.

Authors:  Keisuke Ejima; Ryosuke Omori; Kazuyuki Aihara; Hiroshi Nishiura
Journal:  Int J Biol Sci       Date:  2012-04-23       Impact factor: 6.580

7.  Measles outbreak, the Netherlands, 2008.

Authors:  Susan Hahne; Margreet J M te Wierik; Liesbeth Mollema; Eva van Velzen; Eric de Coster; Corien Swaan; Hester de Melker; Robert van Binnendijk
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

Review 8.  Current perspectives in assessing humoral immunity after measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-12-26       Impact factor: 5.683

9.  A measles epidemic threshold in a highly vaccinated population.

Authors:  Jacco Wallinga; Janneke C M Heijne; Mirjam Kretzschmar
Journal:  PLoS Med       Date:  2005-10-18       Impact factor: 11.069

10.  Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.

Authors:  Iana H Haralambieva; Whitney L Simon; Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Warner; Diane E Grill; Gregory A Poland
Journal:  Viruses       Date:  2015-03-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.